Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors	HER2+ Advanced Breast Cancer; Other Solid Tumors	Not yet recruiting	Phase 1 / Phase 2	2025-09-23		NCT06027983

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National University Hospital, Singapore	120

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials